Literature DB >> 21852113

Differences according to socioeconomic status in the management and mortality in men with high risk prostate cancer.

Anders Berglund1, Hans Garmo, David Robinson, Carol Tishelman, Lars Holmberg, Ola Bratt, Jan Adolfsson, Pär Stattin, Mats Lambe.   

Abstract

BACKGROUND: Outcomes for many cancer forms are associated with socioeconomic status (SES).We investigated if SES was associated with management and mortality in men with high risk prostate cancer.
MATERIAL AND METHODS: A nation-wide population-based cohort in Prostate Cancer Data Base Sweden (PCBaSe), a merged database including data on incident prostate cancer identified in the National Prostate Cancer Register (NPCR) between 1997 and 2006. High risk PCa was defined as T3 tumour, and/or Gleason score 8-10 and/or PSA 20-50 ng/mL. Use of bone scan, curative treatment, and mortality in relation to SES was assessed by logistic, Cox, and competing risk regression with hazard ratios (HR), sub-distributed HR and 95% confidence intervals (CI) adjusted for co-morbidity, age, calendar period and clinical subgroups.
RESULTS: Amongst 17,522 high risk prostate cancer patients, a bone scan was more often performed in higher white-collar than in blue-collar workers (OR 1.30; 95% CI 1.21-1.40). Amongst men without metastases, the likelihood of intention to treat was higher in higher white-collar workers (OR 1.43; 95% CI 1.28-1.57). In men who received curative treatment, the likelihood was higher to undergo radical prostatectomy for higher white-collar patients (OR 1.29; 95% CI 1.10-1.47). In men without metastases, not only overall mortality was lower amongst higher white-collar workers (HR, 0.76; 95% CI 0.60-0.97), but also prostate cancer-specific mortality (sHR 0.70; 95% CI, 0.49-0.99).
CONCLUSIONS: We conclude that socioeconomic disparities in the management and mortality in men with high risk prostate cancer exist also within the setting of a National Health Care System aiming to provide care on equal terms to all residents.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21852113     DOI: 10.1016/j.ejca.2011.07.009

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  15 in total

Review 1.  Research in cancer care disparities in countries with universal healthcare: mapping the field and its conceptual contours.

Authors:  Christina Sinding; Rachel Warren; Donna Fitzpatrick-Lewis; Jonathan Sussman
Journal:  Support Care Cancer       Date:  2014-08-14       Impact factor: 3.603

2.  Eighteen-year follow-up of the Göteborg Randomized Population-based Prostate Cancer Screening Trial: effect of sociodemographic variables on participation, prostate cancer incidence and mortality.

Authors:  Jonas Hugosson; Rebecka Arnsrud Godtman; Sigrid V Carlsson; Gunnar Aus; Anna Grenabo Bergdahl; Pär Lodding; Carl-Gustaf Pihl; Johan Stranne; Erik Holmberg; Hans Lilja
Journal:  Scand J Urol       Date:  2017-12-18       Impact factor: 1.612

3.  Multilevel Factors Associated With Overall Mortality for Men Diagnosed With Prostate Cancer in Florida.

Authors:  Hong Xiao; Fei Tan; Pierre Goovaerts; Askal Ali; Georges Adunlin; Clement K Gwede; Youjie Huang
Journal:  Am J Mens Health       Date:  2013-12-01

4.  Bridging the gap between biologic, individual, and macroenvironmental factors in cancer: a multilevel approach.

Authors:  Shannon M Lynch; Timothy R Rebbeck
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-03-05       Impact factor: 4.254

Review 5.  Health disparities and cancer: racial disparities in cancer mortality in the United States, 2000-2010.

Authors:  Eileen B O'Keefe; Jeremy P Meltzer; Traci N Bethea
Journal:  Front Public Health       Date:  2015-04-15

6.  Unemployment and prostate cancer mortality in the OECD, 1990-2009.

Authors:  Mahiben Maruthappu; Johnathan Watkins; Abigail Taylor; Callum Williams; Raghib Ali; Thomas Zeltner; Rifat Atun
Journal:  Ecancermedicalscience       Date:  2015-05-14

7.  Serum prostate-specific antigen levels and type of work in tire manufacturing workers.

Authors:  Soo-Hyeon Kim; Keun-Ho Jang; Won-Ju Park; Do-Hyeong Kwon; Won-Yang Kang; Hyeong-Min Lim; Jai-Dong Moon
Journal:  Ann Occup Environ Med       Date:  2014-11-04

8.  Causes of death in men with localized prostate cancer: a nationwide, population-based study.

Authors:  Mieke Van Hemelrijck; Yasin Folkvaljon; Jan Adolfsson; Olof Akre; Lars Holmberg; Hans Garmo; Pär Stattin
Journal:  BJU Int       Date:  2015-05-15       Impact factor: 5.588

9.  Socioeconomic status and diagnosis, treatment, and mortality in men with prostate cancer. Nationwide population-based study.

Authors:  Katarina Tomic; Eugenio Ventimiglia; David Robinson; Christel Häggström; Mats Lambe; Pär Stattin
Journal:  Int J Cancer       Date:  2018-02-02       Impact factor: 7.396

10.  Population-based study on use of chemotherapy in men with castration resistant prostate cancer.

Authors:  Ingela Franck Lissbrant; Hans Garmo; Anders Widmark; Pär Stattin
Journal:  Acta Oncol       Date:  2013-02-21       Impact factor: 4.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.